Clinical Trial Update: Dose-escalation Study of Intravenous Liposomal Vinorelbine Tartrate Injection in Patients With Advanced Malignancy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 dose-escalation study of intravenous liposomal vinorelbine tartrate in patients with advanced cancer completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• liposomal vinorelbine tartrate (vinorelbine tartrate (liposomal formulation))

Snippet

Sponsor: Taiwan Liposome Company | Conditions: Cancer | Phase 1, Phase 2 | Status: COMPLETED